Study design, materials and methods
We prospectively studied 45 patients, who underwent HoLEP for benign prostatic hyperplasia performed by a single surgeon between July 2014 and May 2017.All enrolled patients demographic, perioperative, and postoperative data were recorded. On follow-up, International Prostate Symptom Scores (IPSSs), prostate-specific antigen (PSA) levels, QoL scores, peak uroflowmetric data (Qmax values), and post-voiding residual urine volumes (PVR volumes), were recorded. We investigated complications that occurred during and within 3 month after surgery and classified them into grade I to grade V on the basis of the Modified Clavien system. Preoperative vs postoperative findings were compared with Student-t or Fisher-Exact tests.
Interpretation of results
Improvements in IPSSs, Qmax values, and PVR volumes prove that the surgical outcomes are good.QoL scores improved more than 2 times when compared to pre-operative period, one month after surgery.Sexual functioning was improved after HoLEP in our study but not significant values.
The HoLEP procedure helped to preserve sexual functions, but retrograde ejaculation still remains
a problem.Improvements in voiding and sexual activity caused QoL scores to rise.The fall in PSA level may be associated with prostate debulking. The reduction of large post-void residual is due to relieve the obstruction. HoLEP is a safe procedure with acceptable complications and presents an acceptable continence rate.No complication was life-threatening